CRISPR gene editing is revolutionizing the landscape of modern medicine, offering transformative potential in treating genetic disorders like sickle cell disease.As researchers harness CRISPR technology to edit genes, they navigate a complex web of ethical issues, particularly concerning the implications of gene modifications on health equity.